Ligand · O39
O39 · (N-[([2,2'-bipyridin]-5-yl-kappa~2~N~1~,N~1'~)methyl]-3-{[(pyridin-3-yl)methyl]sulfanyl}propanamide)bis[2-(quinolin-2-yl-kappaN)phenyl-kappaC~1~]iridium
O39, (N-[([2,2'-bipyridin]-5-yl-kappa~2~N~1~,N~1'~)methyl]-3-{[(pyridin-3-yl)methyl]sulfanyl}propanamide)bis[2-(quinolin-2-yl-kappaN)phenyl-kappaC~1~]iridium (C50 H40 Ir N6 O S, 965.2 g/mol), in the MolNFT structures on GenesisL1: bound in…
- Component
- O39
- Formula
- C50 H40 Ir N6 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
O39 in 2 structures; the first of them:
- 7UAY · Crystal structure of human CYP3A4 with the caged inhibitor · O39 A602 · binds PHE57, ARG105, ARG106, PHE108, GLY109, SER119, ASP217, PHE220 and 10 more
- 7UAY · Crystal structure of human CYP3A4 with the caged inhibitor · O39 A602 · binds PHE57, ARG105, ARG106, PHE108, GLY109, SER119, ASP217, PHE220 and 10 more
Residues it binds most
PHE 2, ARG 2, GLY 2, LEU 2, THR 2, ALA 2, ASP 2, GLU 2, ILE 2, SER 2 (residue and the binding sites it lines).
Found with
- HEM · Protoporphyrin IX containing Fe
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.